SRTOY Stock: Sartorius Stedim Biotech S.A. Stock Price, Analysis & Insights
Get live SRTOY stock price $20.58, comprehensive Sartorius Stedim Biotech S.A. stock analysis, charts, news, and expert forecast. Real-time SRTOY stock data and investment insights.
Loading chart data...
Sartorius Stedim Biotech S.A. (SRTOY) Overview
Sartorius Stedim Biotech S.A. (SRTOY) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, SRTOY trades at $20.58 with a market capitalization of 200.20B . Over the past 52 weeks, SRTOY has traded between $17.25 and $26.54 , with the current price positioned at approximately 36% of this rang...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 200.20B
- Current price: $20.58
- 52-week range: $17.25 - $26.54
- P/E ratio: 66.39
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Sartorius Stedim Biotech S.A. operates globally, providing essential instruments and consumables to the biopharmaceutical industry. Their product range is extensive, featuring items such as cell lines, cell culture growth media, and bioreactors. The ...
Company Information
- CEO
- Rene Faber
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 9961
Contact Information
- Website
- https://www.sartorius.com
- Address
- Zone Industrielle Les Paluds
- Country
- FR
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 200.2 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 66.4)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sartorius Stedim Biotech S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sartorius Stedim Biotech S.A.
- ⚠Investors should consider how Sartorius Stedim Biotech S.A. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 66.4) requires strong growth to justify
Market Cap
200.20B
P/E Ratio (TTM)
66.39
Beta
1.13
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SRTOY with peer companies:
- Price
- $189.90+0.00% (1D)
- Market cap
- 294.40B
- Price
- $202.80-1.15% (1D)
- Market cap
- 94.13B
- Price
- $102.36-1.46% (1D)
- Market cap
- 94.21B
- Price
- $10.93+0.92% (1D)
- Market cap
- 98.50B
- Price
- $43.34+3.94% (1D)
- Market cap
- 192.55B
- Price
- $144.88+0.00% (1D)
- Market cap
- 276.44B
- Price
- $414.00+1.22% (1D)
- Market cap
- 329.54B
- Price
- $50.42+0.56% (1D)
- Market cap
- 324.75B
- Price
- $411.25+0.00% (1D)
- Market cap
- 327.35B
- Price
- $54.23-1.31% (1D)
- Market cap
- 79.24B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
60/100 ⭐⭐⭐⭐
- Overall
- -1.4%
- NYSE
- -0.6%
- NASDAQ
- -2.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.2% | +1.6% | +1.7% | 19.1 | 100/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.2% | -1.8% | +1.2% | 21.9 | 83/100⭐⭐⭐⭐⭐ |
| Energy | -0.2% | -6.1% | +1.5% | 37.0 | 75/100⭐⭐⭐⭐⭐ |
| Healthcare | -1.4% | -3.7% | -0.5% | 30.2 | 60/100⭐⭐⭐⭐ |
| Technology | -0.8% | -7.7% | +0.0% | 48.7 | 55/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.7% | +3.0% | -1.6% | 31.1 | 50/100⭐⭐⭐ |
| Real Estate | -1.0% | -1.8% | -1.9% | 50.3 | 31/100⭐⭐ |
| Industrials | -2.7% | -7.6% | -2.1% | 41.5 | 30/100⭐⭐ |
| Basic Materials | -1.9% | -6.0% | -3.5% | 26.6 | 28/100⭐⭐ |
| Utilities | -2.1% | -6.9% | -8.5% | 25.3 | 24/100⭐ |
| Consumer Cyclical | -1.5% | -4.5% | -3.4% | 52.2 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.